Summary

The global Hymecromone API market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Hymecromone (4-methylumbelliferone) is a drug used in bile therapy. It is used as choleretic and antispasmodic drugs and as a standard for the fluorometric determination of enzyme activity. Hymecromone is a crystalline solid with a melting point of 194–195 °C. It is soluble in methanol and glacial acetic acid.
In 2025, the Europe Hymecromone API market was US$ million, while the China market stood at US$ million. Europe accounted for % of the global market in 2025 and China for %. China’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Hymecromone API include FARMAK, Guangzhou Hanpu Pharmaceutical, DQA Pharma, Chongqing Xingcan Pharmaceutical, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in Europe accounted for about % of the market in 2025, while the top three in China held nearly %.
The global Hymecromone API market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
FARMAK
Guangzhou Hanpu Pharmaceutical
DQA Pharma
Chongqing Xingcan Pharmaceutical
Segment by Type
98% Purity
99% Purity
Segment by Application
Gallbladder Disease
Pneumonia
Others
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
Europe
China
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Hymecromone API sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Hymecromone API manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Hymecromone API product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Hymecromone API value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Hymecromone API Product Scope
1.2 Hymecromone API by Type
1.2.1 Global Hymecromone API Sales by Type (2021, 2025 & 2032)
1.2.2 98% Purity
1.2.3 99% Purity
1.3 Hymecromone API by Application
1.3.1 Global Hymecromone API Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Gallbladder Disease
1.3.3 Pneumonia
1.3.4 Others
1.4 Global Hymecromone API Market Estimates and Forecasts (2021-2032)
1.4.1 Global Hymecromone API Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Hymecromone API Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Hymecromone API Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Hymecromone API Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Hymecromone API Historical Market Scenario by Region (2021-2026)
2.2.1 Global Hymecromone API Sales Market Share by Region (2021-2026)
2.2.2 Global Hymecromone API Revenue Market Share by Region (2021-2026)
2.3 Global Hymecromone API Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Hymecromone API Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Hymecromone API Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 Europe Hymecromone API Market Size and Prospects (2021-2032)
2.4.2 China Hymecromone API Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Hymecromone API Historical Market Review by Type (2021-2026)
3.1.1 Global Hymecromone API Sales by Type (2021-2026)
3.1.2 Global Hymecromone API Revenue by Type (2021-2026)
3.1.3 Global Hymecromone API Average Price by Type (2021-2026)
3.2 Global Hymecromone API Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Hymecromone API Sales Forecast by Type (2027-2032)
3.2.2 Global Hymecromone API Revenue Forecast by Type (2027-2032)
3.2.3 Global Hymecromone API Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Hymecromone API
4 Global Market Size by Application
4.1 Global Hymecromone API Historical Market Review by Application (2021-2026)
4.1.1 Global Hymecromone API Sales by Application (2021-2026)
4.1.2 Global Hymecromone API Revenue by Application (2021-2026)
4.1.3 Global Hymecromone API Average Price by Application (2021-2026)
4.2 Global Hymecromone API Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Hymecromone API Sales Forecast by Application (2027-2032)
4.2.2 Global Hymecromone API Revenue Forecast by Application (2027-2032)
4.2.3 Global Hymecromone API Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Hymecromone API Applications
5 Competition Landscape by Players
5.1 Global Hymecromone API Sales by Player (2021-2026)
5.2 Global Top Hymecromone API Players by Revenue (2021-2026)
5.3 Global Hymecromone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Hymecromone API revenue as of 2025
5.4 Global Hymecromone API Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Hymecromone API, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Hymecromone API, Product Type & Application
5.7 Global Key Manufacturers of Hymecromone API, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 Europe Market: Players, Segments, Downstream and Major Customers
6.1.1 Europe Hymecromone API Sales by Company
6.1.1.1 Europe Hymecromone API Sales by Company (2021-2026)
6.1.1.2 Europe Hymecromone API Revenue by Company (2021-2026)
6.1.2 Europe Hymecromone API Sales Breakdown by Type (2021-2026)
6.1.3 Europe Hymecromone API Sales Breakdown by Application (2021-2026)
6.1.4 Europe Hymecromone API Major Customers
6.1.5 Europe Market Trends and Opportunities
6.2 China Market: Players, Segments, Downstream and Major Customers
6.2.1 China Hymecromone API Sales by Company
6.2.1.1 China Hymecromone API Sales by Company (2021-2026)
6.2.1.2 China Hymecromone API Revenue by Company (2021-2026)
6.2.2 China Hymecromone API Sales Breakdown by Type (2021-2026)
6.2.3 China Hymecromone API Sales Breakdown by Application (2021-2026)
6.2.4 China Hymecromone API Major Customers
6.2.5 China Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 FARMAK
7.1.1 FARMAK Company Information
7.1.2 FARMAK Business Overview
7.1.3 FARMAK Hymecromone API Sales, Revenue and Gross Margin (2021-2026)
7.1.4 FARMAK Hymecromone API Products Offered
7.1.5 FARMAK Recent Development
7.2 Guangzhou Hanpu Pharmaceutical
7.2.1 Guangzhou Hanpu Pharmaceutical Company Information
7.2.2 Guangzhou Hanpu Pharmaceutical Business Overview
7.2.3 Guangzhou Hanpu Pharmaceutical Hymecromone API Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Guangzhou Hanpu Pharmaceutical Hymecromone API Products Offered
7.2.5 Guangzhou Hanpu Pharmaceutical Recent Development
7.3 DQA Pharma
7.3.1 DQA Pharma Company Information
7.3.2 DQA Pharma Business Overview
7.3.3 DQA Pharma Hymecromone API Sales, Revenue and Gross Margin (2021-2026)
7.3.4 DQA Pharma Hymecromone API Products Offered
7.3.5 DQA Pharma Recent Development
7.4 Chongqing Xingcan Pharmaceutical
7.4.1 Chongqing Xingcan Pharmaceutical Company Information
7.4.2 Chongqing Xingcan Pharmaceutical Business Overview
7.4.3 Chongqing Xingcan Pharmaceutical Hymecromone API Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Chongqing Xingcan Pharmaceutical Hymecromone API Products Offered
7.4.5 Chongqing Xingcan Pharmaceutical Recent Development
8 Hymecromone API Manufacturing Cost Analysis
8.1 Hymecromone API Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Hymecromone API
8.4 Hymecromone API Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Hymecromone API Distributors List
9.3 Hymecromone API Customers
10 Hymecromone API Market Dynamics
10.1 Hymecromone API Industry Trends
10.2 Hymecromone API Market Drivers
10.3 Hymecromone API Market Challenges
10.4 Hymecromone API Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer